What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience

Uterine serous carcinoma accounts for 3–10% of endometrial cancers, but it is the most lethal histopathological subtype. The molecular characterization of endometrial carcinomas has allowed novel therapeutic approaches for these patients. We undertook a retrospective analysis of patients with uterin...

Full description

Bibliographic Details
Published in:	Current Oncology
Main Authors:	Michalis Liontos, Anna Svarna, Charalampos Theofanakis, Oraianthi Fiste, Angeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios Athanasios Dimopoulos, Flora Zagouri
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Subjects:	cancer endometrial p53 abnormal expression survival
Online Access:	https://www.mdpi.com/1718-7729/28/6/410

Similar Items

Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies
by: Angeliki Andrikopoulou, et al.
Published: (2024-12-01)

<i>BRCA1/2</i> Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
by: Michalis Liontos, et al.
Published: (2021-11-01)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
by: Michalis Liontos, et al.
Published: (2021-03-01)

Molecular Prognostic Factors in Uterine Serous Carcinomas: A Systematic Review
by: Anna Svarna, et al.
Published: (2025-04-01)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
by: Oraianthi Fiste, et al.
Published: (2021-04-01)

CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience
by: Angeliki Andrikopoulou, et al.
Published: (2021-06-01)

“The emerging role of capivasertib in breast cancer”
by: Angeliki Andrikopoulou, et al.
Published: (2022-06-01)

Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents
by: Flora Zagouri, et al.
Published: (2022-09-01)

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
by: Michalis Liontos, et al.
Published: (2021-10-01)

The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis
by: Angeliki Andrikopoulou, et al.
Published: (2022-01-01)

Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience
by: Maria Kaparelou, et al.
Published: (2022-04-01)

Fertility-Sparing Treatment for Young Patients with Early-Stage Cervical Cancer: A Dawn of a New Era
by: Charalampos Theofanakis, et al.
Published: (2022-05-01)

Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials
by: Kleoniki Apostolidou, et al.
Published: (2024-06-01)

Paraneoplastic pemphigus associated with squamous cell carcinoma of the cervix
by: Fiste O., et al.
Published: (2022-09-01)

Detection of High-Grade Cervical Intraepithelial Neoplasia by Electrical Impedance Spectroscopy in Women Diagnosed with Low-Grade Cervical Intraepithelial Neoplasia in Cytology
by: Georgios Panagakis, et al.
Published: (2023-10-01)

Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis
by: Vasilios Pergialiotis, et al.
Published: (2022-08-01)

Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature
by: Alkistis Papatheodoridi, et al.
Published: (2023-05-01)

Correction to: Trastuzumab administration during pregnancy: an update
by: Angeliki Andrikopoulou, et al.
Published: (2021-12-01)

Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
by: Dimopoulos Athanassios-Meletios, et al.
Published: (2010-12-01)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
by: Evangelos Terpos, et al.
Published: (2021-05-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021-06-01)

The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.
by: Sofia-Paraskevi Trachana, et al.
Published: (2016-01-01)

Clinico Pathological Analysis of Uterine Serous Carcinoma in a Cancer Centre from Northern Kerala-A Retrospective Study
by: Indusarath, et al.
Published: (2018-05-01)

Editorial: PARP inhibitors resistance: new insights in ovarian cancer therapy
by: Oraianthi Fiste, et al.
Published: (2025-09-01)

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes
by: Simou Maria, et al.
Published: (2011-11-01)

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
by: Efthymia Skafida, et al.
Published: (2023-01-01)

Uterine Serous Carcinoma Arising From Endometrial Polyp: A Case Report
by: Sibel Bektaş, et al.
Published: (2009-04-01)

Impact of positive cytology in uterine serous carcinoma: A reassessment
by: Logan Corey, et al.
Published: (2021-08-01)

The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients: Systematic Review and Meta-Analysis
by: Vasilios Pergialiotis, et al.
Published: (2024-04-01)

Preoperative Bowel Preparation in Minimally Invasive and Vaginal Gynecologic Surgery
by: Michail Diakosavvas, et al.
Published: (2020-01-01)

Abnormal Uterine Bleeding- evaluation by Endometrial Aspiration
by: Pratibha Singh
Published: (2018-01-01)

To do or not to do? – Endometrial biopsy in younger women with abnormal uterine bleeding
by: Sandra Lynn Jaya-Bodestyne, et al.
Published: (2025-03-01)

PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance
by: Zhang T, et al.
Published: (2021-12-01)

Retrospective examination of endometrial sampling results in women with abnormal uterine bleeding
by: Reyhan Aydın Doğan, et al.
Published: (2023-04-01)

Prevalence and characteristics of endometrial polyps in patients with abnormal uterine bleeding
by: Đorđević Biljana, et al.
Published: (2008-01-01)

Histopathology-like categories based on endometrial imprint cytology in dysfunctional uterine bleeding
by: Seema N Baxi, et al.
Published: (2015-01-01)

Multiparametric MRI-based radiomics and deep learning for differentiating uterine serous carcinoma from endometrioid carcinoma: a multicenter retrospective study
by: Yi Shen, et al.
Published: (2025-10-01)

Spectrum of Uterine corpus lesions in hysterectomy specimens
by: Sharadrutha A1 , Janaki M2
Published: (2017-08-01)

Markers of proliferation and angiogenesis in endometrial hyperplastic processes combined with uterine fibroids
by: Yu. Ya. Krut, et al.
Published: (2020-04-01)

Defining Oligometastatic Bladder Cancer: A Systematic Review
by: Aristotelis Bamias, et al.
Published: (2023-09-01)